Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria
Open Access
- 3 July 2024
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 103 (10) , 4021-4031
Abstract
This study aims to analyze the risk factors for the development of multidrug-resistant (MDR) and carbapenem-resistant (CR) bacteria bloodstream infection (BSI) in a patient with acute leukemia (AL) and the mortality in gram-negative bacteria (GNB) BSI. This is a retrospective study conducted at West China Hospital of Sichuan University, which included patients diagnosed with AL and concomitant GNB BSI from 2016 to 2021. A total of 206 patients with GNB BSI in AL were included. The 30-day mortality rate for all patients was 26.2%, with rates of 25.8% for those with MDR GNB BSI and 59.1% for those with CR GNB BSI. Univariate and multivariate analyses revealed that exposure to quinolones (Odds ratio (OR) = 3.111, 95% confidence interval (95%CI): 1.623–5.964, p = 0.001) within the preceding 30 days was an independent risk factor for MDR GNB BSI, while placement of urinary catheter (OR = 6.311, 95%CI: 2.478–16.073, p < 0.001) and exposure to cephalosporins (OR = 2.340, 95%CI: 1.090–5.025, p = 0.029) and carbapenems (OR = 2.558, 95%CI: 1.190–5.497, p = 0.016) within the preceding 30 days were independently associated with CR GNB BSI. Additionally, CR GNB BSI (OR = 2.960, 95% CI: 1.016–8.624, p = 0.047), relapsed/refractory AL (OR = 3.035, 95% CI: 1.265–7.354, p = 0.013), septic shock (OR = 5.108, 95% CI: 1.794–14.547, p = 0.002), platelets < 30 × 109/L before BSI (OR = 7.785, 95% CI: 2.055–29.492, p = 0.003), and inappropriate empiric antibiotic therapy (OR = 3.140, 95% CI: 1.171–8.417, p = 0.023) were independent risk factors for 30-day mortality in AL patients with GNB BSI. Prior antibiotic exposure was a significant factor in the occurrence of MDR GNB BSI and CR GNB BSI. CR GNB BSI increased the risk of mortality in AL patients with GNB BSI.Keywords
Funding Information
- 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (No. ZYJC21007)
- Key Research and Development Program of Sichuan Province (No. 2023YFS0031)
- National Key Research and Development Program of China (No. 2022YFC2502600, 2022YFC2502603)
- National Natural Science Foundation of China (No. 82370192)
This publication has 40 references indexed in Scilit:
- Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 yearsClinical and Experimental Medicine, 2023
- Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropeniaThe Brazilian Journal of Infectious Diseases, 2023
- Antimicrobial resistance: new insights and therapeutic implicationsApplied Microbiology and Biotechnology, 2022
- Inappropriate initial antimicrobial therapy for hematological malignancies patients with Gram-negative bloodstream infectionsInfection, 2019
- Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignanciesAnnals of Hematology, 2018
- Prognostic factors and scoring model of hematological malignancies patients with bloodstream infectionsInfection, 2018
- Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013International Journal of Antimicrobial Agents, 2017
- Bloodstream infections caused by Klebsiella pneumoniae in onco‐hematological patients: clinical impact of carbapenem resistance in a multicentre prospective surveyAmerican Journal of Hematology, 2016
- Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective surveyClinical Microbiology and Infection, 2015
- Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patientsIntensive Care Medicine, 2013